Study of YK012 in B-cell Acute Lymphoblastic Leukemia

Key facts

Sponsor

Excyte Biopharma Ltd

Principal Investigator

Jie Jin, MD

Zhejiang University

Intervention

YK012(drug)

Enrollment

46 enrolled

Eligibility

18-75 years · All sexes

Timeline

2024 – 2027

Study locations (12)

• Sun Yat-sen Memorial Hospital, Guangzhou, Guangdong, China
• Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China
• Guangdong Provincial People's Hospital, Guangzhou, Guangdong, China
• The Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, China
• Henan Provincial People's Hospital, Zhengzhou, Henan, China
• The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China
• The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China
• The First Hospital of Jilin University, Changchun, Jilin, China
• Affiliated Zhongshan Hospital of Dalian University, Dalian, Liaoning, China
• Shengjing Hospital of China Medical University, Shenyang, Liaoning, China
• The Second Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China
• The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for Acute lymphoblastic leukemia

Additional recruiting or active studies for the same condition.

• RECRUITINGNANCT05621291
  A Study to Evaluate Next-Generation Sequencing (NGS) Testing and Monitoring of B-cell Recovery to Guide Management Following Chimeric Antigen Receptor T-cell (CART) Induced Remission in Children and Young Adults With B Lineage Acute Lymphoblastic Leu...
  National Cancer Institute (NCI)
• RECRUITINGPHASE2NCT06738368
  Etoposide, Prednisone, Vincristine, Cyclophosphamide, and Doxorubicin (DA-EPOCH) With or Without Rituximab Plus Recombinant Erwinia Asparaginase (JZP458) for the Treatment of Newly Diagnosed Ph Negative B-Acute Lymphoblastic Leukemia or T Acute Lymphoblastic Leukemia
  University of Washington
• ENROLLING BY INVITATIONNCT07511959
  Autologous Exosomes From Platelet-rich Plasma as a Modern Tool of Regenerative Dentistry
  Wroclaw Medical University
• RECRUITINGNANCT07191119
  Transcutaneous Auricular Vagus Nerve Stimulation for Insomnia in Survivors of Childhood Acute Lymphoblastic Leukemia
  St. Jude Children's Research Hospital
• RECRUITINGNANCT07177183
  Low Serum Creatinine as a Predictor of Prolonged Mechanical Ventilation and Weaning Failure
  University Hospital Ostrava
• RECRUITINGPHASE2NCT07275762
  Y-4 to Treat the Postherpetic Neuralgia
  Neurodawn Pharmaceutical Co., Ltd.
• RECRUITINGNANCT07201974
  Virtual Reality for Post-Stroke Gait Rehabilitation
  McGill University
• ENROLLING BY INVITATIONNCT07515430
  The Association Between Gut Microbiome Composition Signature and Cancer-related Symptoms in Children With Acute Lymphoblastic Leukemia
  Sun Yat-sen University

See all trials for Acute lymphoblastic leukemia →